These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25010585)

  • 21. Pharmacotherapy for women's sexual dysfunction.
    Basson R
    Expert Opin Pharmacother; 2009 Jul; 10(10):1631-48. PubMed ID: 19527189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishing a Rationale for Compounding Hormone Replacement Therapy.
    Biundo B
    Int J Pharm Compd; 2018; 22(3):190-195. PubMed ID: 29878886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants and frequency of pharmaceutical compounding in pharmacy practice in Palestine.
    Zaid AN; Al-Ramahi R; Shahed Q; Saleh B; Elaraj J
    Int J Pharm Pract; 2012 Feb; 20(1):9-14. PubMed ID: 22236175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioidentical hormones: what is all the hype about?
    Panay N; Fenton A
    Climacteric; 2010 Feb; 13(1):1-3. PubMed ID: 20067429
    [No Abstract]   [Full Text] [Related]  

  • 25. Exemplary programs on midlife women's health issues in managed care settings.
    Rolnick SJ; Fortman KK; Bloom F
    Am J Manag Care; 1999 Aug; 5(8):995-1003. PubMed ID: 10558131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormones and quality of life after surgical menopause.
    Utian WH
    J Womens Health (Larchmt); 2006 Oct; 15(8):975-6. PubMed ID: 17087621
    [No Abstract]   [Full Text] [Related]  

  • 27. No fountain of youth: FDA and NIH review off-label use of hormones.
    Hanna KE
    Hastings Cent Rep; 2003; 33(4):8-9. PubMed ID: 12971054
    [No Abstract]   [Full Text] [Related]  

  • 28. Compounding practices and beliefs of Arizona pharmacists.
    Cauthon KA; Bowman BJ; Gurney MK
    Int J Pharm Compd; 2013; 17(2):154-61. PubMed ID: 23696176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The standardization of nonsterile compounding: a study in quality control and assessment for hormone compounding.
    Wiley TS; Odegard RD; Raden J; Haraldsen JT
    Int J Pharm Compd; 2014; 18(2):162-8. PubMed ID: 24881121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insight into the treatment of vulvar pain: a survey of clinicians.
    Updike GM; Wiesenfeld HC
    Am J Obstet Gynecol; 2005 Oct; 193(4):1404-9. PubMed ID: 16202733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic vulvar pain in a cohort of post-menopausal women: Atrophy or Vulvodynia?
    Mitro SD; Harlow SD; Randolph JF; Reed BD
    Womens Midlife Health; 2016; 2():. PubMed ID: 28127441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of women in the United States with localized, provoked vulvodynia: practice survey of women's health physical therapists.
    Hartmann D; Strauhal MJ; Nelson CA
    J Reprod Med; 2007 Jan; 52(1):48-52. PubMed ID: 17286069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compounded estradiol cream: a cost conscious alternative.
    Barenberg BJ; Smith T; Nihira MA
    J Okla State Med Assoc; 2014 Apr; 107(4):155-6. PubMed ID: 24902419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testosterone supplementation in women: prescribing practices in one community.
    Freeman MP
    J Womens Health (Larchmt); 2004 Mar; 13(2):239-40. PubMed ID: 15072739
    [No Abstract]   [Full Text] [Related]  

  • 35. Menopausal hormone therapy and menopausal symptoms.
    Al-Safi ZA; Santoro N
    Fertil Steril; 2014 Apr; 101(4):905-15. PubMed ID: 24613533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users.
    Lawton B; Rose S; McLeod D; Dowell A
    BMJ; 2003 Oct; 327(7419):845-6. PubMed ID: 14551101
    [No Abstract]   [Full Text] [Related]  

  • 37. The multifaceted nature of access to compounded progesterone: a cross-sectional study from Australia.
    Spark MJ; Willis J; Byrne G; Iacono T
    Maturitas; 2014 Feb; 77(2):155-62. PubMed ID: 24274917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From the challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health.
    Gambacciani M; Genazzani AR
    Gynecol Endocrinol; 2006 Mar; 22(3):115-6. PubMed ID: 16835071
    [No Abstract]   [Full Text] [Related]  

  • 39. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of symptoms in relation to androgen concentrations in women using estrogen plus progestogen and women using estrogen alone.
    Spetz AC; Fredriksson MG; Lidfeldt J; Samsioe GN
    Menopause; 2009; 16(1):149-55. PubMed ID: 18779755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.